Men with incurable prostate cancer are facing a “postcode lottery of care”, a charity warned, after it raised concerns that some patients may not get access to a new drug approved for NHS use in England.
The National Institute for Health and Care Excellence (Nice) has given the green light for a new “gentler” treatment for prostate cancer among men whose disease has spread to other parts of the body.
